Navigation Links
Cancer Antibodies: Drug Target Atlas and Competitive Outlook
Date:11/15/2012

Treatment of Thymoma Cancer 895Table 140: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Thyroid Cancer 896Table 141: The Competition through Close Mechanistic Approximation between Thyroid Cancer Drugs 896Table 142: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Unspecified Cancer Type 898Table 143: The Competition through Close Mechanistic Approximation between Unspecified Cancer Type Drugs 902Table 144: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Vaccine adjunct 905Table 145: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Waldenstrom's hypergammaglobulinemia 906Table 146: The Competition through Close Mechanistic Approximation between of Waldenstrom's hypergammaglobulinemia Drugs 906Table 147: Competitive Summary by Investigator of Antibody Drug Development in Cancer 908Table 148: Summary Table of Corporate Changes in the Competitive Landscape of Cacner Antibody Drug Development 913Table 149: The Worst Ranking and the Highest Populated Level for Each of the 15 Ranking Parameters 916Table 150: Example of a Competitive Fall-Out Table (Targeting TNFSF11 Modified) 922Table 151: A&G Pharmaceutical's Included Antibody Drugs in Oncology and Competitive Fall-Out 926Table 152: Abbott's Included Antibody Drugs in Oncology and Competitive Fall-Out 931Table 153: Abcam's Included Antibody Drugs in Oncology and Competitive Fall-Out 941Table 154: Abiogen's Included Antibody Drugs in Oncology and Competitive Fall-Out 949Table 155: Ablynx's Included Antibody Drugs in Oncology and Competitive Fall-Out 957Table 156: AC Immune's Included Antibody Drugs in Oncology and Competitive Fall-Out 961Table 157: Acceleron Pharma's Included Antibody Drugs in Oncology and Competitive Fall-Out 965Table 158: Access' Included Antibody Drugs in Oncology and Competitive Fall-Out 970Table 159: Actinium Pharmaceuticals' Included Antibody Drugs in Oncology and Competitive Fall-Out
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
3. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
4. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
5. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
6. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
7. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
8. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
9. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
10. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
11. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Ouagadougou, Burkina Faso (PRWEB) July 10, 2014 ... Burkina Faso, today have access to an additional ... to increase access to contraception at all levels ... combining a lower-dose formulation of a widely used ... injection system. , Burkina Faso is the first ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Product ... in very low abundance and are often “lost ... and time-consuming. , Join presenters Dr. Rowel Tobias, ... Dr. John Anders, Head of Quality at Nanotherapeutics, ... approach that can speed detection and quantitation while ...
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
(Date:7/10/2014)... 10, 2014 Understanding the need for ... lines, and the gap that currently exists in this ... its industry-leading portfolio of validated ion channel and GPCR ... cell lines, as ion channels control many critical physiological ... activity creates the potential to treat a variety of ...
Breaking Biology Technology:Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3
... February 26 Arpida Ltd.,(SWX: ARPN) today reported that ... intravenous iclaprim in its first indication,complicated Skin and Skin ... weeks., Arpida has agreed with the U.S. Food ... rolling process. Using a ,rolling NDA, allows modules,within the ...
... Therapeutics,Inc. (Nasdaq: TPTX ) today announced that ... TorreyPines, will present at Susquehanna,Financial Group,s Second Annual ... on Tuesday, March 4th at 11:00 a.m., Eastern., ... be available live. You can,access the webcast at: ...
... BURLINGTON, Mass., Feb. 26 Hyaluron ... development,services, continued to expand its business in ... and staffing increasing greater than 60 percent ... HCM acquired,additional space at its Burlington MA ...
Cached Biology Technology:Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 2Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 3TorreyPines Therapeutics to Present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference 2HCM Announces Substantial Growth in 2007 2
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
(Date:7/10/2014)... , June 27, 2014  The American Academy ... Institute of Standards and Technology (NIST) and the ... academic research and forensic science expert members to ... is an element of the NIST,s Organization of ... among the first appointments made to the new ...
(Date:7/10/2014)... 2014  Pomerantz LLP has filed a class ... the "Company")(NYSE-MKT: PVCT) and certain of its officers.  ... Court, Middle District of Tennessee ... class consisting of all persons or entities who ... 17, 2013 and May 22, 2014, both dates ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
... sequenced an ancient RNA genome of a barley virus once ... back at least 2,000 years and revealing how intense farming at ... the University of Warwick have detected and sequenced the RNA genome ... found at a site near the River Nile in modern-day Egypt. ...
... Research UFZ present CLIMBER: Climatic niche characteristics ... on the climatic niche characteristics of 397 European butterflies ... provided in this dataset is of great relevance for ... high quality standards and open access, data ready to ...
... establish a state of the art Microbiorefinery (MBR) to ... Fossil fuel sources currently provide the basis for ... supplies and environmental considerations mean there is a growing ... The new facility, in collaboration with ...
Cached Biology News:RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 2RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 3Unique new dataset CLIMBER: Climatic niche characteristics of the butterflies in Europe 2University of Liverpool to establish microbiorefinery facility 2
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Integrins Sampler Kit 10g each...
PKC Sampler Kit 10 mu g each...
Golgi Sampler Kit 10g each...
Biology Products: